Earnings Per Share, Basic in USD/shares of Vanda Pharmaceuticals Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2010 to Q3 2025.
  • Vanda Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.38 USD/shares, a 322% decline year-over-year.
  • Vanda Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -1 USD/shares, a 393% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2024 was -0.33 USD/shares, a 925% decline from 2023.
  • Vanda Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was 0.04 USD/shares, a 63.6% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was 0.11 USD/shares, a 81.7% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Vanda Pharmaceuticals Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 $0 $0 -322% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 -$1 $0 $0 -475% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $0 -$1 $0 -614% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $0 $0 $0 -80% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-14
Q3 2024 $0 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 $0 $0 $0 -367% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $0 $0 $0 -217% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $0 $0 $0 -145% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-14
Q3 2023 $0 $0 $0 -100% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $0 $0.03 $0 -40% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $0 $0.06 +$0.17 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $0 $0.11 $0 -15.4% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-14
Q3 2022 $0 $0.06 $0 -57.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 $0.05 $0 -70.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $0 $0 $0 -169% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $0 $0.13 $0 -13.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-08
Q3 2021 $0 $0.14 +$0.03 +27.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $0 $0.17 +$0.01 +6.25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 $0.16 +$0.15 +1500% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $0 $0.15 +$0.07 +87.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-11
Q3 2020 $0 $0.11 -$2 -94.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.00 $0.16 $0 -27.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $2.00 $0.01 +$0.02 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $2.00 $0.08 $0 -60% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-11
Q3 2019 $2.00 $1.88 +$1.74 +1243% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-11
Q2 2019 $0 $0.22 +$0.13 +144% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-11
Q1 2019 $0 $0 $0 -114% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-11
Q4 2018 $0 $0.20 +$0.25 Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $0 $0.14 +$0.24 Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 $0 $0.09 +$0.12 Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 $0 $0.07 +$0.24 Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 $0 $0 Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2014 $0 $1.85 +$2.08 Oct 1, 2014 Dec 31, 2014 10-K 2016-02-12
Q3 2014 -$1 $0 +$0.13 +76.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-12
Q2 2014 -$1 -$1 -$1 -482% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-12
Q1 2014 -$1 -$1 -$1 -427% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-12
Q4 2013 $0 $0 $0 0% Oct 1, 2013 Dec 31, 2013 10-K 2014-02-25
Q3 2013 $0 $0 +$0.02 +10.5% Jul 1, 2013 Sep 30, 2013 10-K 2014-02-25
Q2 2013 $0 $0 +$0.17 +60.7% Apr 1, 2013 Jun 30, 2013 10-K 2014-02-25
Q1 2013 $0 $0 +$0.13 +46.4% Jan 1, 2013 Mar 31, 2013 10-K 2014-02-25
Q4 2012 $0 $0 $0 -15% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 $0 $0 $0 -72.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 $0 $0 $0 -460% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 $0 $0 $0 Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q4 2011 $0 $0 Oct 1, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 $0 $0 -200% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-26
Q2 2011 $0 $0 -200% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-26
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $0.11 Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $0.05 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05

Vanda Pharmaceuticals Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 $0 -925% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 $0.04 $0 -63.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $0.11 $0 -81.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-14
2021 $0.60 +$0.17 +39.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-08
2020 $0.43 -$2 -80.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $2.17 +$1.67 +334% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $0.50 +$0.85 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $0 +$0.06 +14.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $0 +$0.53 +56.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 -$1 -$2 -262% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $0.58 +$1.27 Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 -$1 +$0.32 +31.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 -$1 -$1 -189% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $0 -$1 -235% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $0.26 Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.